Global Subcutaneous Biologics Market Size, Share, and COVID-19 Impact Analysis, By Type of Biologic (Antibodies, Nucleotides, and Proteins), By Method of Administration (Injection, Infusion, and Both (Injection & Infusion)), By Therapeutic Area (Autoimmune Disorders, Bone Diseases, Hematological Disorders, Infectious Diseases, Inflammatory Disorders, Metabolic Disorders, Neurological Disorders, Ocular Disorders, Oncological Disorders, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE May 2025
REPORT ID SI10461
PAGES 240
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type of Biologic
      2. Market Attractiveness Analysis By Method of Administration
      3. Market Attractiveness Analysis By Therapeutic Area
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Growing technological advancements in subcutaneous drug delivery
      2. Shift towards self-administration therapies
    3. Restraints
      1.  Challenges associated with the subcutaneous biologics formulation
    4. Opportunities
      1.  Increasing demand for self-administerable therapies and availability of user-friendly drug delivery devices
    5. Challenges
      1. Product recalls, side effects, and strict regulatory approvals
  6. Global Subcutaneous Biologics Market Analysis and Projection, By Type of Biologic
    1. Segment Overview
    2. Antibodies
    3. Nucleotides
    4. Proteins
  7. Global Subcutaneous Biologics Market Analysis and Projection, By Method of Administration
    1. Segment Overview
    2. Injection
    3. Infusion
    4. Both (Injection & Infusion)
  8. Global Subcutaneous Biologics Market Analysis and Projection, By Therapeutic Area
    1. Segment Overview
    2. Autoimmune Disorders
    3. Bone Diseases
    4. Hematological Disorders
    5. Infectious Diseases
    6. Others
  9. Global Subcutaneous Biologics Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Subcutaneous Biologics Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Subcutaneous Biologics Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1. Adocia
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Alteogen 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Ascendis Pharma 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   CD Bioparticles 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Creative Biolabs 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Creative BioMart
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Foresee Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Pacira Biosciences
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Wyss Institute
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  Xeris Biopharma 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  2. Global Antibodies, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  3. Global Nucleotides, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  4. Global Proteins, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  5. Global Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  6. Global Injection, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  7. Global Infusion, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  8. Global Both (Injection & Infusion), Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  9. Global Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  10. Global Autoimmune Disorders, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  11. Global Bone Diseases, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  12. Global Hematological Disorders, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  13. Global Infectious Diseases, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  14. Global Others, Subcutaneous Biologics Market, By Region, 2024-2035(USD Billion)
  15. North America Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  16. North America Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  17. North America Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  18. U.S.  Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  19. U.S.  Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  20. U.S.  Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  21. Canada Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  22. Canada Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  23. Canada Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  24. Mexico Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  25. Mexico Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  26. Mexico Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  27. Europe Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  28. Europe Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  29. Europe Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  30. Germany Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  31. Germany Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  32. Germany Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  33. France Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  34. France Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  35. France Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  36. U.K.  Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  37. U.K.  Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  38. U.K.  Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  39. Italy Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  40. Italy Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  41. Italy Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  42. Spain Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  43. Spain Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  44. Spain Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  45. Asia Pacific Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  46. Asia Pacific Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  47. Asia Pacific Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  48. Japan Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  49. Japan Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  50. Japan Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  51. China Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  52. China Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  53. China Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  54. India Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  55. India Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  56. India Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  57. South America Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  58. South America Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  59. South America Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  60. Brazil Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  61. Brazil Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  62. Brazil Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  63. The Middle East and Africa Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD   Billion)
  64. The Middle East and Africa Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD   Billion)
  65. The Middle East and Africa Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  66. UAE Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  67. UAE Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  68. UAE Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)
  69. South Africa Subcutaneous Biologics Market, By Type of Biologic, 2024-2035(USD Billion)
  70. South Africa Subcutaneous Biologics Market, By Method of Administration, 2024-2035(USD Billion)
  71. South Africa Subcutaneous Biologics Market, By Therapeutic Area, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Subcutaneous Biologics Market Segmentation
  2. Subcutaneous Biologics Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Subcutaneous Biologics Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Subcutaneous Biologics Market
  20. Subcutaneous Biologics Market Segmentation, By Type of Biologic
  21. Subcutaneous Biologics Market For Antibodies, By Region, 2024-2035 ($ Billion)
  22.  Subcutaneous Biologics Market For Nucleotides, By Region, 2024-2035 ($ Billion)
  23. Subcutaneous Biologics Market For Proteins, By Region, 2024-2035 ($ Billion)
  24.  Subcutaneous Biologics Market Segmentation, By Method of Administration
  25.  Subcutaneous Biologics Market For Injection, By Region, 2024-2035 ($ Billion)
  26.  Subcutaneous Biologics Market For Infusion, By Region, 2024-2035 ($ Billion)
  27. Subcutaneous Biologics Market For Both (Injection & Infusion), By Region, 2024-2035 ($ Billion)
  28. Subcutaneous Biologics Market Segmentation, By Therapeutic Area
  29. Subcutaneous Biologics Market For Autoimmune Disorders, By Region, 2024-2035 ($ Billion)
  30. Subcutaneous Biologics Market For Bone Diseases, By Region, 2024-2035 ($ Billion)
  31. Subcutaneous Biologics Market For Hematological Disorders, By Region, 2024-2035 ($ Billion)
  32. Subcutaneous Biologics Market For Infectious Diseases, By Region, 2024-2035 ($ Billion)
  33. Subcutaneous Biologics Market For Others, By Region, 2024-2035 ($ Billion)
  34. Adocia: Net Sales, 2024-2035 ($ Billion)
  35. Adocia: Revenue Share, By Segment, 2024 (%)
  36. Adocia: Revenue Share, By Region, 2024 (%)
  37. Alteogen: Net Sales, 2024-2035 ($ Billion)
  38. Alteogen: Revenue Share, By Segment, 2024 (%)
  39. Alteogen: Revenue Share, By Region, 2024 (%)
  40. Ascendis Pharma: Net Sales, 2024-2035 ($ Billion)
  41. Ascendis Pharma: Revenue Share, By Segment, 2024 (%)
  42. Ascendis Pharma: Revenue Share, By Region, 2024 (%)
  43. CD Bioparticles: Net Sales, 2024-2035 ($ Billion)
  44. CD Bioparticles: Revenue Share, By Segment, 2024 (%)
  45. CD Bioparticles: Revenue Share, By Region, 2024 (%)
  46. Creative Biolabs: Net Sales, 2024-2035 ($ Billion)
  47. Creative Biolabs: Revenue Share, By Segment, 2024 (%)
  48. Creative Biolabs: Revenue Share, By Region, 2024 (%)
  49. Creative BioMart: Net Sales, 2024-2035 ($ Billion)
  50. Creative BioMart: Revenue Share, By Segment, 2024 (%)
  51. Creative BioMart: Revenue Share, By Region, 2024 (%)
  52. Foresee Pharmaceuticals: Net Sales, 2024-2035 ($ Billion)
  53. Foresee Pharmaceuticals: Revenue Share, By Segment, 2024 (%)
  54. Foresee Pharmaceuticals: Revenue Share, By Region, 2024 (%)
  55. Pacira Biosciences: Net Sales, 2024-2035 ($ Billion)
  56. Pacira Biosciences: Revenue Share, By Segment, 2024 (%)
  57. Pacira Biosciences: Revenue Share, By Region, 2024 (%)
  58. Wyss Institute.: Net Sales, 2024-2035 ($ Billion)
  59. Wyss Institute.: Revenue Share, By Segment, 2024 (%)
  60. Wyss Institute.: Revenue Share, By Region, 2024 (%)
  61. Xeris Biopharma: Net Sales, 2024-2035 ($ Billion)
  62. Xeris Biopharma: Revenue Share, By Segment, 2024 (%)
  63. Xeris Biopharma: Revenue Share, By Region, 2024 (%)
  64. Others: Net Sales, 2024-2035 ($ Billion)
  65. Others: Revenue Share, By Segment, 2024 (%)
  66. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:120
Pages:240
Countries covered:17
Companies covered::20
Forecast CAGR:11.05%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies